Literature DB >> 1317752

Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry.

C K Chung1, H N Antoniades.   

Abstract

In situ hybridization and immunocytochemistry have been applied to investigate the expression of c-sis/platelet-derived growth factor (PDGF)-B, insulin-like growth factor (IGF)-I, and transforming growth factor alpha mRNAs and their respective receptor mRNAs in three primary human gastric carcinomas and in their adjacent nonmalignant mucosas. Expression of c-sis/PDGF-B mRNA and PDGF-receptor beta mRNA was seen in the tumor cells of the three gastric cancer specimens but not in their adjacent nonmalignant mucosa. The mRNA expression was accompanied by the expression of their respective protein products. IGF-I, IGF-I receptor, and epidermal growth factor receptor mRNAs were seen in both the tumor cells of the gastric cancer specimens and in nonmalignant mucosa. Transforming growth factor alpha mRNA was expressed in gastric tumor cells but not in nonmalignant mucosa. The coexpression of a potent "competence" growth factor, PDGF, and "progression" growth factors, IGF-I and transforming growth factor alpha, in the tumor cells of gastric carcinomas may contribute to their growth and maintenance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317752

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Expression of transforming growth factor alpha in human tissues: immunohistochemical study and northern blot analysis.

Authors:  W Yasui; Z Q Ji; H Kuniyasu; A Ayhan; H Yokozaki; H Ito; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  A rare case of gastric cancer in an acromegalic patient.

Authors:  K Asai; S Shimoyama; N Sanno; M Kaminishi; T Oohara
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 3.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 4.  Targeting receptor tyrosine kinases in gastric cancer.

Authors:  Asahiro Morishita; Jian Gong; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy?

Authors:  Daniel Drescher; Markus Moehler; Ines Gockel; Kirsten Frerichs; Annett Müller; Friedrich Dünschede; Thomas Borschitz; Stefan Biesterfeld; Martin Holtmann; Thomas Wehler; Andreas Teufel; Kerstin Herzer; Thomas Fischer; Martin R Berger; Theodor Junginger; Peter R Galle; Carl C Schimanski
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

7.  Identification and validation of genes involved in gastric tumorigenesis.

Authors:  Neelakantan Vijayalakshmi; Gopisetty Gopal; Thangarajan Rajkumar; Kesavan Sabitha; Sundersingh Shirley; Uthandaraman M Raja; Seshadri A Ramakrishnan
Journal:  Cancer Cell Int       Date:  2010-11-24       Impact factor: 5.722

8.  Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.

Authors:  Shioto Suzuki; Yoh Dobashi; Yayoi Hatakeyama; Ryosuke Tajiri; Takashi Fujimura; Carl H Heldin; Akishi Ooi
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

9.  Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  Biswajit Mukherjee; Shampa Ghosh; Tanushree Das; Manika Doloi
Journal:  J Carcinog       Date:  2005-08-10

Review 10.  Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy.

Authors:  Marius Raica; Anca Maria Cimpean
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.